Literature DB >> 24679497

Role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension.

Richard Parker1.   

Abstract

A transjugular intrahepatic portosystemic shunt (TIPS) is an expandable metal stent inserted via the jugular vein that creates a shunt from the portal vein to the systemic circulation via an artificial communication through the liver. It is used to treat complications of portal hypertension. In addition to rescue treatment in variceal bleeding, TIPS can play an important role in prevention of rebleeding. TIPS can improve symptoms if medical treatment of ascites or hepatic hydrothrorax has failed, but may not improve survival. Selected cases of Budd-Chiari syndrome improve with TIPS. This article discusses the indications, evidence, and complications of TIPS.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ascites; Portal hypertension; Transjugular intrahepatic portosystemic shunt; Varices

Mesh：

Year:  2014        PMID： 24679497     DOI： 10.1016/j.cld.2013.12.004

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN： 1089-3261            Impact factor:   6.126


  9 in total

1.  Therapeutic effects and complications of simplified pericardial devascularization for patients with portal hypertension.

Authors:  Hongwei Lu; Sida Liu; Yafei Zhang; Hao Shang; Hong Ji; Yiming Li
Journal:  Int J Clin Exp Med       Date:  2015-08-15

2.  Emergency Transjugular Intrahepatic Portosystemic Shunt: an Effective and Safe Treatment for Uncontrolled Variceal Bleeding.

Authors:  Yongjun Zhu; Xiaoze Wang; Xiaotan Xi; Xiao Li; Xuefeng Luo; Li Yang
Journal:  J Gastrointest Surg       Date:  2019-02-21       Impact factor: 3.452

3.  Budd-Chiari syndrome: a single-center experience.

Authors:  Tanya M Pavri; Alan Herbst; Rajender Reddy; Kimberly A Forde
Journal:  World J Gastroenterol       Date:  2014-11-21       Impact factor: 5.742

4.  Endovascular stenting of the inferior vena cava in a patient with Budd-Chiari syndrome and main hepatic vein thrombosis: a case report.

Authors:  Young-In Yoon; Shin Hwang; Gi-Young Ko; Tae-Yong Ha; Gi-Won Song; Dong-Hwan Jung; Young-Sang Lee; Sung-Gyu Lee
Journal:  Korean J Hepatobiliary Pancreat Surg       Date:  2015-02-28

5.  Combined transjugular intrahepatic portosystemic shunt and other interventions for hepatocellular carcinoma with portal hypertension.

Authors:  Bin Qiu; Meng-Fei Zhao; Zhen-Dong Yue; Hong-Wei Zhao; Lei Wang; Zhen-Hua Fan; Fu-Liang He; Shan Dai; Jian-Nan Yao; Fu-Quan Liu
Journal:  World J Gastroenterol       Date:  2015-11-21       Impact factor: 5.742

6.  Race and Gradient Difference Are Associated with Increased Risk of Hepatic Encephalopathy Hospital Admission After Transjugular Intrahepatic Portosystemic Shunt Placement.

Authors:  Michael W Rowley; Myunghan Choi; Steve Chen; Kevin Hirsch; Anil B Seetharam
Journal:  J Clin Exp Hepatol       Date:  2017-12-30

7.  Combination therapy versus pharmacotherapy, endoscopic variceal ligation, or the transjugular intrahepatic portosystemic shunt alone in the secondary prevention of esophageal variceal bleeding: a meta-analysis of randomized controlled trials.

Authors:  Lu-Lu Lin; Shi-Ming Du; Yan Fu; Hui-Yun Gu; Lei Wang; Zhi-Yuan Jian; Xian-Feng Shen; Jie Luo; Chao Zhang
Journal:  Oncotarget       Date:  2017-05-24

8.  Partial spleen embolization reduces the risk of portal hypertension-induced upper gastrointestinal bleeding in patients not eligible for TIPS implantation.

Authors:  Matthias Buechter; Alisan Kahraman; Paul Manka; Guido Gerken; Alexander Dechêne; Ali Canbay; Axel Wetter; Lale Umutlu; Jens M Theysohn
Journal:  PLoS One       Date:  2017-05-11       Impact factor: 3.240

Review 9.  Indian College of Radiology and Imaging Evidence-Based Guidelines for Interventions in Portal Hypertension and Its Complications.

Authors:  Amar Mukund; Shaleen Rana; Chander Mohan; Naveen Kalra; Sanjay Saran Baijal
Journal:  Indian J Radiol Imaging       Date:  2022-01-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.